Shoreline Biosciences Finds $140M
socalTECH
NOVEMBER 2, 2021
The funding was led by Ally Bridge Group, and also included new investors Eventide Asset Management, BeiGene, Irving Investors, Kingdon, NS Investment, Piper Heartland Healthcare Capital, and Superstring, along with current investors Boxer Capital, BVF Partners, L.P.,
Let's personalize your content